🔗 Share this article

This year's prestigious award in medical science was awarded for revolutionary discoveries that clarify how the immune system targets harmful infections while sparing the healthy tissues.

A trio of esteemed scientists—Japan's Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their work uncovered unique "security guards" within the defense system that eliminate malfunctioning defense cells that could attacking the organism.

These discoveries are now paving the way for innovative treatments for immune disorders and cancer.

These laureates will divide a prize fund worth 11 million SEK.

Decisive Discoveries

"The work has been essential for comprehending how the immune system functions and why we don't all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

This trio's research address a core mystery: How does the immune system defend us from numerous infections while leaving our healthy cells unharmed?

The immune system employs immune cells that scan for signs of infection, even viruses and bacteria it has never encountered.

These defenders utilize sensors—known as receptors—that are produced by chance in countless combinations.

That provides the defense network the capacity to fight a wide array of invaders, but the unpredictability of the process unavoidably creates white blood cells that may target the host.

Security Guards of the Immune System

Researchers earlier knew that some of these harmful white blood cells were eliminated in the thymus—where immune cells mature.

This year's Nobel Prize recognizes the discovery of T-reg cells—described as the body's "security guards"—which travel through the body to neutralize other defenders that attack the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

The prize committee stated, "These findings have laid the foundation for a novel area of investigation and accelerated the development of new therapies, for example for tumors and immune disorders."

Regarding cancer, T-regs prevent the system from fighting the tumor, so studies are focused on lowering their quantity.

For autoimmune diseases, experiments are exploring increasing regulatory T-cells so the organism is not being harmed. A similar method could also be effective in minimizing the risks of organ transplant rejection.

Pioneering Studies

Professor Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland extracted, leading to autoimmune disease.

He demonstrated that introducing immune cells from other mice could prevent the disease—suggesting there was a mechanism for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic immune disorder in mice and humans that resulted in the identification of a genetic factor vital for how regulatory T-cells operate.

"Their pioneering work has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," said a prominent biological science specialist.

"The work is a striking illustration of how fundamental physiological research can have broad implications for public health."